InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Aguilar-Cordova Estuardo, Directeur Scientifique. Officer active across 1 companies, notably Candel Therapeutics, Inc.. In total, 3 reports have been published. The latest transaction was disclosed on 6 May 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations3 total
€187,260135,183 shares@ €1.38520.060% mcap100.0% of flow
Common Stock
SEC:0000899243-22-017474:0·
162,137 shares
Common Stock
SEC:0000899243-21-031103·
162,137 shares
Common Stock
SEC:0000899243-21-031103:0·
3 of 3 declarations
About Aguilar-Cordova Estuardo
Estuardo Aguilar-Cordova is the Chief Scientific Officer of Candel Therapeutics, Inc. In this role, he oversees the company's research and development initiatives, focusing on innovation and the advancement of therapies. His responsibilities include leading scientific teams and collaborating with other departments to ensure that research projects align with the company's strategic objectives.
